Brainwave Entrainment During Emergence (BB_emergence)

February 17, 2023 updated by: Jeong-Hwa Seo, Seoul National University Hospital

The Effect of Binaural Sound on Recovery of General Anesthesia in Patients Undergoing Laparoscopic Simple Gynecological Surgery

The investigators will compare whether there is a significant difference in the time required for general anesthesia recovery according to application of the binaural sound after surgery.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

After entering the operating room, electrocardiogram, pulse oxygen saturation, blood pressure meter, and sedline are attached to start monitoring vital signs and patient state index (PSI). propofol and the remifentanil continuous infusion device is connected as close as possible to the catheter insertion site. Anesthesia is induced with total intravenous anesthesia (4 ng/mL of Remifentanil, 4 mg/mL of propofol). Rocuronium is administered after checking the patient's unconsciousness. When appropriate neuromuscular blocking is reached, tracheal intubation is performed. The anesthesia maintenance is performed to keep stable vital sign and PSI between 25 and 50. End-tidal carbon dioxide is controlled to be between 30 mmHg and 40 mmHg.

When the pneumoperitoneum ends, the propofol concentration is recorded (T0). The anesthesiologist in charge of anesthesia puts headphones on the patient and plays the allocated file. The allocated file is named the screening number. Depending on the allocated group, the audio file is binaural sound for the experimental group, and a silent file for the control group.

The anesthesiologist cannot know group allocation, since the length and size of files are the same. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and record the time (T1). At the same time, the investigators reverse neuromuscular blocking using sugammadex (2mg/ kg).

When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Record the time (T2) when the PSI reaches 50, the time when the patient opens eyes (T3), and the time (T4) when the extubation of endotracheal tube was done. T3-T1 is the time it took the patient to open his eyes (primary end point). Write the effect site concentration of propofol and remifentanil recorded for each time points.

The patient's sedline EEG data from the end of pneumoperitoneum until the patient's exit operating room is collected as raw data. The patient's blood pressure and heart rate are measured at each time points. The investigators evaluate sedation and agitation of the patients using Ramsay Sedation Scale.

In the post-anesthesia care unit, pain score (NRS 0-10), postoperative nausea vomiting, medication, and length of stay are investigated.

Study Type

Interventional

Enrollment (Anticipated)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients between 19 and 50 years of age who are scheduled to undergo laparoscopic salpingo-oophorectomy/ ovarian cystectomy
  • Intellectual level to understand the procedures of the clinical trial
  • Physical status classification of the American Society of Anesthesiology (ASA) 1-2 grades

Exclusion Criteria:

  • Patients with hearing loss or using hearing aids
  • Patients who have been given narcotic painkillers or sedative drugs within a week.
  • Alcohol-dependent or drug-dependent patients
  • Patients with drug hypersensitivity to anesthetics
  • Patients with arrhythmia, cardiovascular disease, impaired heart function, decreased circulatory blood flow
  • Patients with liver failure
  • Patients with other major medical or psychological disorder that will affect the treatment response
  • Patients with claustrophobia or anxiety disorder
  • Patients with organic brain disorders or other conditions that cannot be properly measured by PSI
  • Patients who have been newly diagnosed with myocardial infarction, cerebral ischemic seizure, stroke, clinically significant coronary artery disease, or have undergone percutaneous carotid coronary dilatation or coronary bypass treatment within 6 months
  • Patients with a history of epilepsy or seizures
  • Patients with acute angle glaucoma
  • Patients who deemed unsuitable for this clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Binaural
Exposed to binaural sound (40 Hz) from the end of pneumoperitoneum until the eyes are open
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the experimental group, the allocated file is binaural sound with 40Hz beat. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.
Active Comparator: Control
Applied silent files from the end of pneumoperitoneum until the eyes are open
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the control group, the allocated file is silent. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eye opening time
Time Frame: after the anesthetic infusion is terminated until 1 hour
The time it takes to open patient's eyes in response to the voice after the anesthetic infusion is terminated.
after the anesthetic infusion is terminated until 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extubation time
Time Frame: after the anesthetic infusion is terminated until 1 hour
The time it takes from the end of the anesthetic infusion to the extubation of endotracheal tube
after the anesthetic infusion is terminated until 1 hour
Systolic blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
Noninvasive systolic blood pressure
from the end of the anesthetic infusion to the exit of operating room until 1 hour
Diastolic blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
Noninvasive diastolic blood pressure
from the end of the anesthetic infusion to the exit of operating room until 1 hour
Mean blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
Noninvasive mean blood pressure
from the end of the anesthetic infusion to the exit of operating room until 1 hour
Heart rate
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
Heart rate
from the end of the anesthetic infusion to the exit of operating room until 1 hour
alpha band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
alpha band activity of electroencephalogram from Sedline data
from the end of the anesthetic infusion to the exit of operating room until 1 hour
beta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
beta band activity of electroencephalogram from Sedline data
from the end of the anesthetic infusion to the exit of operating room until 1 hour
theta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
theta band activity of electroencephalogram from Sedline data
from the end of the anesthetic infusion to the exit of operating room until 1 hour
delta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
delta band activity of electroencephalogram from Sedline data
from the end of the anesthetic infusion to the exit of operating room until 1 hour
Ramsay Sedation Scale
Time Frame: When the end of anesthesia within 5minutes
The degree of patient's sedation or agitation (1 to 6: 1 means "Patient is anxious and agitated or restless, or both"; 6 means "Patient exhibits no response")
When the end of anesthesia within 5minutes
Postoperative recovery score
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
Postoperative recovery score (0-10; activity (0-2), respiration (0-2), circulation (0-2), consciousness level (0-2), and color (0-2); optimum score 10)
When the patient stay in post-anesthesia care unit up to 1 hour
Pain score
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
Postoperative pain score using numeric rating scale(0-10: 0, no pain; 10, worst possible pain)
When the patient stay in post-anesthesia care unit up to 1 hour
Rate of postoperative nausea and vomiting
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
Rate of postoperative nausea and vomiting
When the patient stay in post-anesthesia care unit up to 1 hour
Length of stay in post-anesthesia care unit
Time Frame: From entering to exit the post-anesthesia care unit up to 2 hours
Length of stay in post-anesthesia care unit
From entering to exit the post-anesthesia care unit up to 2 hours
Medication
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
Rate of administration of any medication in post-anesthesia care unit
When the patient stay in post-anesthesia care unit up to 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 15, 2023

Primary Completion (Anticipated)

November 15, 2023

Study Completion (Anticipated)

February 23, 2024

Study Registration Dates

First Submitted

February 2, 2023

First Submitted That Met QC Criteria

February 17, 2023

First Posted (Estimate)

February 20, 2023

Study Record Updates

Last Update Posted (Estimate)

February 20, 2023

Last Update Submitted That Met QC Criteria

February 17, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2212-028-1383

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe